157 related articles for article (PubMed ID: 33336886)
1. Cellular Fucosylation Inhibitors Based on Fluorinated Fucose-1-phosphates*.
Pijnenborg JFA; Visser EA; Noga M; Rossing E; Veizaj R; Lefeber DJ; Büll C; Boltje TJ
Chemistry; 2021 Feb; 27(12):4022-4027. PubMed ID: 33336886
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of fucosylation by 2-fluorofucose suppresses human liver cancer HepG2 cell proliferation and migration as well as tumor formation.
Zhou Y; Fukuda T; Hang Q; Hou S; Isaji T; Kameyama A; Gu J
Sci Rep; 2017 Sep; 7(1):11563. PubMed ID: 28912543
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two glycoengineering strategies to control the fucosylation of a monoclonal antibody.
Mishra N; Spearman M; Donald L; Perreault H; Butler M
J Biotechnol; 2020; 324S():100015. PubMed ID: 34154738
[TBL] [Abstract][Full Text] [Related]
4. Fluorinated rhamnosides inhibit cellular fucosylation.
Pijnenborg JFA; Rossing E; Merx J; Noga MJ; Titulaer WHC; Eerden N; Veizaj R; White PB; Lefeber DJ; Boltje TJ
Nat Commun; 2021 Dec; 12(1):7024. PubMed ID: 34857733
[TBL] [Abstract][Full Text] [Related]
5. Two pathways for importing GDP-fucose into the endoplasmic reticulum lumen function redundantly in the O-fucosylation of Notch in Drosophila.
Ishikawa HO; Ayukawa T; Nakayama M; Higashi S; Kamiyama S; Nishihara S; Aoki K; Ishida N; Sanai Y; Matsuno K
J Biol Chem; 2010 Feb; 285(6):4122-4129. PubMed ID: 19948734
[TBL] [Abstract][Full Text] [Related]
6. Engineering nucleotide sugar synthesis pathways for independent and simultaneous modulation of N-glycan galactosylation and fucosylation in CHO cells.
Prabhu A; Shanmugam D; Gadgil M
Metab Eng; 2022 Nov; 74():61-71. PubMed ID: 36152932
[TBL] [Abstract][Full Text] [Related]
7. 2-Fluoro-L-Fucose Is a Metabolically Incorporated Inhibitor of Plant Cell Wall Polysaccharide Fucosylation.
Villalobos JA; Yi BR; Wallace IS
PLoS One; 2015; 10(9):e0139091. PubMed ID: 26414071
[TBL] [Abstract][Full Text] [Related]
8. An Alkynyl-Fucose Halts Hepatoma Cell Migration and Invasion by Inhibiting GDP-Fucose-Synthesizing Enzyme FX, TSTA3.
Kizuka Y; Nakano M; Yamaguchi Y; Nakajima K; Oka R; Sato K; Ren CT; Hsu TL; Wong CH; Taniguchi N
Cell Chem Biol; 2017 Dec; 24(12):1467-1478.e5. PubMed ID: 29033318
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of fucosylation by 2-fluorofucose attenuated acetaminophen-induced liver injury
Liu Z; Tu M; Shi J; Zhou H; Meng G; Gu J; Wang Y
Front Pharmacol; 2022; 13():939317. PubMed ID: 36120347
[TBL] [Abstract][Full Text] [Related]
10. Development of orally active inhibitors of protein and cellular fucosylation.
Okeley NM; Alley SC; Anderson ME; Boursalian TE; Burke PJ; Emmerton KM; Jeffrey SC; Klussman K; Law CL; Sussman D; Toki BE; Westendorf L; Zeng W; Zhang X; Benjamin DR; Senter PD
Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5404-9. PubMed ID: 23493549
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic and Prophylactic Antitumor Activity of an Oral Inhibitor of Fucosylation in Spontaneous Mammary Cancers.
Disis ML; Corulli LR; Gad EA; Koehnlein MR; Cecil DL; Senter PD; Gardai SJ; Okeley NM
Mol Cancer Ther; 2020 May; 19(5):1102-1109. PubMed ID: 32165557
[TBL] [Abstract][Full Text] [Related]
12. Impact of Acetylated and Non-Acetylated Fucose Analogues on IgG Glycosylation.
Zimmermann M; Ehret J; Kolmar H; Zimmer A
Antibodies (Basel); 2019 Jan; 8(1):. PubMed ID: 31544815
[TBL] [Abstract][Full Text] [Related]
13. Core fucosylation of N-linked glycans in leukocyte adhesion deficiency/congenital disorder of glycosylation IIc fibroblasts.
Sturla L; Fruscione F; Noda K; Miyoshi E; Taniguchi N; Contini P; Tonetti M
Glycobiology; 2005 Oct; 15(10):924-34. PubMed ID: 15917429
[TBL] [Abstract][Full Text] [Related]
14. Incorporation of fucose into glycans independent of the GDP-fucose transporter SLC35C1 preferentially utilizes salvaged over de novo GDP-fucose.
Skurska E; Szulc B; Maszczak-Seneczko D; Wiktor M; Wiertelak W; Makowiecka A; Olczak M
J Biol Chem; 2022 Aug; 298(8):102206. PubMed ID: 35772493
[TBL] [Abstract][Full Text] [Related]
15. The fucose salvage pathway inhibits invadopodia formation and extracellular matrix degradation in melanoma cells.
Keeley T; Lin S; Lester DK; Lau EK; Yang S
PLoS One; 2018; 13(6):e0199128. PubMed ID: 29924834
[TBL] [Abstract][Full Text] [Related]
16. Differential terminal fucosylation of N-linked glycans versus protein O-fucosylation in leukocyte adhesion deficiency type II (CDG IIc).
Sturla L; Rampal R; Haltiwanger RS; Fruscione F; Etzioni A; Tonetti M
J Biol Chem; 2003 Jul; 278(29):26727-33. PubMed ID: 12738772
[TBL] [Abstract][Full Text] [Related]
17. Synthetic Fluorinated l-Fucose Analogs Inhibit Proliferation of Cancer Cells and Primary Endothelial Cells.
Dai Y; Hartke R; Li C; Yang Q; Liu JO; Wang LX
ACS Chem Biol; 2020 Oct; 15(10):2662-2672. PubMed ID: 32930566
[TBL] [Abstract][Full Text] [Related]
18. The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice.
Belcher JD; Chen C; Nguyen J; Abdulla F; Nguyen P; Nguyen M; Okeley NM; Benjamin DR; Senter PD; Vercellotti GM
PLoS One; 2015; 10(2):e0117772. PubMed ID: 25706118
[TBL] [Abstract][Full Text] [Related]
19. Glycomic Profiling Highlights Increased Fucosylation in Pseudomyxoma Peritonei.
Saarinen L; Nummela P; Leinonen H; Heiskanen A; Thiel A; Haglund C; Lepistö A; Satomaa T; Hautaniemi S; Ristimäki A
Mol Cell Proteomics; 2018 Nov; 17(11):2107-2118. PubMed ID: 30072579
[TBL] [Abstract][Full Text] [Related]
20. Notch deficiency implicated in the pathogenesis of congenital disorder of glycosylation IIc.
Ishikawa HO; Higashi S; Ayukawa T; Sasamura T; Kitagawa M; Harigaya K; Aoki K; Ishida N; Sanai Y; Matsuno K
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18532-7. PubMed ID: 16344471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
